ARCHIVES

In this 12-page issue: Moonlighting by NCI and FDA scientists conflicted with CRADA work, House Subcommittee on Oversight and Investigations says.

This article is from The Cancer Letter archive.

Vol. 30 No. 21 | May 21, 2004

Download PDF Visit The Full Archive

Related Articles

NCI Halts Routine P01 Site Visits Due to Travel Cut

February 7, 1992

Bush Budget Stresses Research Now, Public Health Interventions Later.

April 13, 2001

ASCO, AACR Hold Last Joint annual Meeting, Vow to Encourage Basic-Clinical Interaction

May 28, 1993

Racial Disparities Remain In Breast Cancer Care

October 29, 2010

Molecular target Drug Discovery Grants; Unanimously Approved

July 2, 1999

Cooperative Groups: Insurers Agree To Cover Patient Care Costs In Group Trials

September 26, 1997